Rubicon Research Limited β Q2FY27 earnings call summary
Filed 12 November 2026 Β· Official transcript
- Three manufacturing sites pre-revenue; Pithampur to start FY28; others timeline uncertain
- Q2 FY27 revenue grew 40% y-y to INR577 Cr; EBITDA INR146 Cr, PAT INR90 Cr
- Operating EBITDA margin guided at 24%+ for full FY27
- H1 FY27 revenue INR1,111 Cr (+45% y-y); PAT INR175 Cr (+80% y-y)
- Sequential USD revenue growth 5% in Q2; specialty products drive stable pricing and gross profit
- Arinna acquisition included; focus on growth before margin improvement
- R&D spend steady at ~10.8% of revenue; productivity improving with 5.8x revenue growth impact
- Regulatory inspections recent; observations procedural, no data integrity issues
Open source transcript Β· View Rubicon Research Limited research
Sign in free to track Rubicon Research Limited and receive future summaries.